Spa Biotech Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 90.00 K
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
About Spa Biotech Pharma
Spa Biotech Pharma Private Limited (SBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 May 2018 (Six years and eight months 28 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 90.00 K , as per Ministry of Corporate Affairs (MCA) records.
Anil Ghogare, Sheela Ghogare, Manasi Ghogare, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2018PTC309077
-
Company No.
309077
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 May 2018
-
Date of AGM
28 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Spa Biotech Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Ghogare
|
Director | 08-May-2018 | Current |
|
Sheela Ghogare
|
Director | 08-May-2018 | Current |
|
Manasi Ghogare
|
Director | 08-May-2018 | Current |
|
Prachi Ghogare
|
Director | 08-May-2018 | Current |
Financial Performance of Spa Biotech Pharma.
Enhance accessibility to Spa Biotech Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spa Biotech Pharma?
Unlock access to Spa Biotech Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Unimax Laboratories Private LimitedAnil Ghogare is a mutual person
-
Vital Laboratories Private LimitedAnil Ghogare is a mutual person
-
Skyvin Healthcare Private LimitedAnil Ghogare is a mutual person
-
Kimika Gmpsol Private Limited
Anil Ghogare, Sheela Ghogare and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spa Biotech Pharma?
Unlock and access historical data on people associated with Spa Biotech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spa Biotech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spa Biotech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.